Loss of ZNF451 mediates fibroblast activation and promotes lung fibrosis

Area of Science:

• Molecular Biology
• Pathogenesis Research
• Fibrosis Studies

Background:

• Pulmonary fibrosis (PF) lacks effective therapies due to unclear molecular mechanisms.
• Zinc finger protein 451 (ZNF451), a transcriptional regulator, has unknown roles in PF.
• This study investigates ZNF451's function in lung fibrosis pathogenesis.

Purpose of the Study:

• To determine the expression pattern of ZNF451 in PF.
• To elucidate the functional role of ZNF451 in PF progression.
• To explore the underlying molecular mechanisms of ZNF451 in lung fibrosis.

Main Methods:

• Analysis of GEO datasets, RT-PCR, and immunoblotting for ZNF451 expression.
• Utilizing ZNF451 knockout mice and lentiviral overexpression to assess PF progression.
• Employing migration assays, immunofluorescence, and RNA-seq for mechanistic investigations.

Main Results:

• ZNF451 is downregulated in PF and correlates negatively with disease severity.
• ZNF451 knockout exacerbates PF, while overexpression protects against bleomycin-induced PF.
• ZNF451 downregulation promotes fibroblast activation via PDGFB and PI3K/Akt signaling.

Conclusions:

• ZNF451 plays a critical role in PF progression and fibroblast activation.
• ZNF451 represents a novel therapeutic target for pulmonary fibrosis.
• Strategies to enhance ZNF451 expression may offer promising therapeutic avenues for PF.